Search

everythinglearnresearchcommunity

for

Search:↓

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Abrocitinib may effectively treat Lichen Planopilaris.

MK-5108 is safe and shows potential against tumors, especially alone.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Ruxolitinib can help regrow hair in severe alopecia areata.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Etanercept effectively treated a severe skin condition when other treatments failed.

CTP-543 is generally safe for treating alopecia areata.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

AH-001 could be a safer and more effective treatment for hair loss.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Axitinib treatment turned a man's grey hair back to black.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

Afatinib often causes skin problems that need proactive management.